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Abstract

Metastatic
melanoma
is usually
a highly
lethal
human cancer.
Great
strides
in melanoma
therapy
have been made in the last
decade,
but
these
gains
in therapy
are mainly
due to earlier
diagnosis
of the disease
and hence initiating
treatment
at an earlier
stage
when the disease
is
more responsive
to treatment.
The complete
clinical
elimination
of melanoma,
and for cancer
in general,
will
require
inhibition
of the
metastatic
process.
Insight
into
the metastatic
process
can be gained
by the study
of tumor cell
invasion,
a subset
of metastasis.
Invasion
may be
defined
as the ability
of cancer
cells
to break
down and travel
through
underlying
basement
membrane and connective
tissue.
The study of
tumor cell
invasion
is complicated
by the need for
a model system
that
provides
for an accurate
measure
of tumor invasion
and an ability
to
recover
invasive
cells
for further
study.
There
are various
in vitro
invasion
assay
systems
which
meet to varying
degrees
the above two
prerequisites.
These assays
include
endothelial
cells
(Kramer et al.,
1980),
blood vessels
(Jones,
1982),
cartilagenous
matrices
(Pauli
and Kuettner,
1982),
embryo organ cultures
(Mareel,
1982),
human
amnion (Liotta
et al.,
1980a),
and nuclepore
filters
(Tullberg
and Burger,
1985).
Additional
in vitro
invasion
assay
systems
may be found in
the review
by Russo et al.
(1982).
The human
amniotic
basement
membrane (HABM) assay
(Liotta
et
al.,
1980a) was utilized
in this
study
to
determine
melanoma cell
invasion
rates.
A
Membrane Invasion
Culture
System (MICS) chamber,
developed
by Gehlsen
et al.
(1984)
and originally
presented
for quantification
by Hendrix
et al.
(1985),
was used in this
study.
The MICS chamber
allows
for quantification
of invasion
and for
recovery
of invasive
cells
for subsequent
study.
The murine
Bl6-Fl0
melanoma cell
line was
used to study
invasiveness.
Murine Bl6-Fl0
cells
are highly
metastatic
and metastasize
primarily
to
the lungs.
Successive
in vivo selection
of the
Bl6-Fl
cell
line
to theB16-FlO
cell
line is
paralleled
by an increase
in their
invasive
capability
as witnessed
by an increase
in the
number of nodules
in murine
lungs
(Fidler,
1973;
1975).
This study
investigated
in vitro
invasion
rates
for Bl6-Fl0
cells
for eachofsix
passages

Bl6-Fl0
cells,
Invasion
Basement
Membrane Model,
Tumor, Cancer,
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Introduction

Invasion
by murine
B16-F10 melanoma
cells
was
studied
using
the human amniotic
basement
membrane
(HABM) assay.
B16-Fl0
cells
were collected
after
a single
passage
through
the amnion and grown to
near confluency.
The cycle
of plating,
passaging,
collecting,
and culturing
Bl6-Fl0
cells
was
repeated
five
times.
The invasion
rate
for
Bl6-Fl0
cells
remained
relatively
unchanged
after
six passages
through
the amnion.
Injection
of
first-passage
Bl6-F10
cells
into C57BL6 mice
resulted
in 29 lung tumors per animal
whereas
sixth-passage
cells
resulted
in 300+ lung tumors.
While there
exists
no correlation
of the number of
cells
penetrating
the amnion with colonization
number,
lung colonization
appears
correlated
with
increased
number of passages
through
the amnion.
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through the amnion.
The in vivo metastatic
ability
of Bl6-Fl0 cells was studied
by comparing
the number of lung tumor nodules formed in mice
injected
with Bl6-Fl0 cells
that passed through
the membrane once with those cells
that passed
through the membrane six times.
Materials

were emptied and rinsed with PBS. The MICS
chamber was then opened and the amnion removed
intact.
Fluid in each of the bottom wells was
agitated
with a pipette.
Samples were pipetted
from the bottom wells to determine
viability
(trypan
blue exclusion
method) and to count the
number of invasive
cells
(standard
hemocytometer
method).
Evaluation
of each well was done in
triplicate
to determine
both viability
and the
number of invading
cells.
The percent
invasion
rate was defined
as the number of cells
per ml of
fluid
in the bottom well of a MICS chamber divided
by lxlo5 (number of cells
plated
per ml into the
top well).
The remaining
fluid
in the bottom
wells was then harvested
and placed into a T-75
flask or a 24 well tissue
culture
plate containing
DMEMplus 107. FBS and 17. PSF. Flasks and plates
were placed in the incubator
at 37°C in 57. CO and
2
95% air.
Bl6-Fl0 cells
were then grown to near
conf uency, harvested,
counted,
and reseeded
at
lxlO
cells
per well into a MICS chamber.
Amnions
from the MICS chambers were fixed in 107. buffered
normal formalin
for light microscopic
studies.
In Vivo Assay
Female C57BL6 mice (Cumberland View Farms,
Clinton,
Tennessee)
were used to check the in vivo
metastatic
capability
of the Bl6-Fl0 cells.-Complete methodologies
on this lung metastasis
assay have been published
(Fidler,
1978; Ostrowski
et al.,
1986).
Two nearly
confluent
T-75 flasks
of Bl6-Fl0 cells,
that had undergone one passage
through the human amniotic
basement membrane, were
suspended in PBS and adjusted
to 500,000 cells
per
ml.
Twenty 75 day old mice were then injected
using the lateral
tail vein with 0.2ml of PBS
containing
100,000 Bl6-Fl0 cells.
Any mice that
were not completely
and successfully
injected
were
discarded.
Mice were then killed
after
15 days.
The lungs were placed in PBS and the metastatic
nodules were immediately
counted under a stereo
dissecting
microscope
at 6.4x magnification.
In
addition
to the lungs, a gross examination
was
made of all thoracic
and abdominal viscera,
thoracic
and abdominal body walls,
brain,
inguinal
nodes, axillary
nodes, back, shoulder,
and
subcutaneous
regions.
The entire
injection
procedure
was repeated
on seventeen
mice with
Bl6-Fl0 cells
that underwent five additional
passages
through the HABMwith the exception
that
mice were one day older.
Electron
Microscopy
The murine Bl6-Fl0 melanoma cell line was
grown to near confluency
in DMEMplus 107. FBS and
17. PSF in T75 flasks.
Cell pellets
were made from
the cell line before
the first
amniotic
passage.
Bl6-Fl0 cell pellets
were also made after
the
first
and sixth passage through the amnion.
All
cell pellets
were processed
for routine
transmission
electron
microscopy
and examined with
a Hitachi
H-600 transmission
electron
microscope.
Lung biopsies
from passage one and passage six
injected
mice were also processed
for routine
transmission
electron
microscopy.

and Methods

Routine Cell Culture
Murine Bl6-Fl0 melanoma cells
(DCT Tumor
Repository,
NCI-Frederick
Cancer Research
Facility,
Frederick,
Maryland 21701) were cultured
in T75 flasks
containing
Dulbecco's
Modified
Eagles Medium (DMEM) plus 107. fetal
bovine serum
(FBS) and 17. penicillin-streptomycin-fungizone
(PSF).
Cell cultures
were refed every three days
and were split
before becoming confluent.
The
length of trypsinization
with VMF trypsin
(Worthington
Diagnostic
Systems,
Inc.,
Freehold,
New Jersey)
was kept to two minutes or less in
order to reduce the effect
on the cells'
metastatic
potential.
Cells were incubated
at
37°C in 57. CO2 and 957. air.
All other parameters
for tissue
culture
were routine.
Human Amniotic Basement Membrane Assay
Fresh human placentas
were obtained
immediately
following
normal term delivery.
The
amnion, which consists
of an epithelium,
a
basement membrane, and a collagenous
stroma, was
removed from the ·underlying
chorion and placed in
an embroidery
ring (Persky et al.,
1984).
The
amnion was then rinsed
in distilled
water to
remove blood from its surface.
The epithelium
was
removed by adding 0.25M ammonium hydroxide
at room
temperature
and agitating
constantly
for seven
minutes.
The amnion was rinsed with distilled
water until
the pH of the amnion reached 7.4 and
then immersed in phosphate
buffered
saline
(PBS).
The amnion was placed in a Sterilguard
Hood (Baker
Co., Sanford,
Maine), washed 2X each side with PBS
(pH 7.4),
treated
with 6.7% fungizone,
washed 2X
with PBS, and placed in a Membrane Invasion
Culture
System (MICS) chamber.
Bottom wells
contained
DMEMplus 107. FBS and 17. PSF. Top wells
were washed with 6.7% fungizone,
washed with and
then filled
with PBS (pH 7.4) and placed in the
incubator
for 30 min.
In order to access
epithelial
removal by the ammonium hydroxide
treatment
at this step of the protocol,
selected
intact
and denuded amnions were processed
for
scanning electron
microscopy.
Tissue was fixed
overnight
in cacodylate
buffered
aldehydes
(3%
glutaraldehyde,
37. paraformaldehyde),
post-fixed
in 27. osmium tetroxide
buffered
in 1.0 N
cacodylate
buffer,
rinsed
in 1.0 N cacodylate
buffer,
dehydrated
in ascending
concentrations
of
acetone,
critical
point dried with CO (Denton
DCT-1), mounted on specimen stubs with copper
tape, coated with gold-palladium
(Hummer VI), and
observed with a scanning electron
microscope
(ISI
SX30).
Murine Bl6-Fl0 melanoma cells
were harvested
from log phase growth.
After removing the PBS
from the top wells Bl6-Fl0 cells
were pipett~d
onto the membrane at a concentration
of lxlO
cells
per well in DMEMcontaining
107. FBS and 1%
PSF. The MICS chambers were incubated
at 37°c in
57. CO and 957. air.
After 3 days the top wells
2
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Figure 1 outlines
the experimental
procedure.
viability(>
96%) was determined
by trypan
exclusion
tests
immediately
before plating

In vitro

CD original

vs.

in vivo

stock of 816-FlO cells

invasion

rates

TABLE 1.

Bl6-Fl0
amniotic

invasion
passages

Amnion
Passage No
TEM

passage #1 subcu1tu re

for different

Percent
Invasion
Rate

1
2
3
4
5
6

----amnion

rates

1. 7+.6a
2.8+.4
2.4:f:.2b
8.3+.9
2.0+.5
2.0+.3

n=3
n=3
n=3
n=6
n=6
n=6

a

bstandard
error
invasion
rate significantly
1,2,3,5,&6
(p<0.01)
according
comparisons
between individual
based on the least
significant
and Torrie,
1960).

ta i1 injections
TEM

L

different
from
to statistical
invasion
rates
difference
(Steel

TEM
TABLE 2.

STEPA

repeat step A to obtain subculture
passages #'s 3, 4, 5 & 6

Number of murine lung nodules
from passage one Bl6-Fl0 cells

Mouse number:

1

2

3

4

5

6

7

Number of lung
metastases
at
6.4x

43

24

49

28

19

17

23

Mean + standard

deviation=

29.0 + 12.3

TEM

TABLE 3.

Fig.

1.

Schematic
protocol.

diagram

Mouse

of the experimental

Number of murine
from passage six

number:

Number of lung
metastases
at 6 .4x:

the cells
on the amnion.
The initial
in vitro
invasion
rate for Bl6-Fl0 cells
was 1.7%.~
invasion
rate was 2.0% after
five additional
successive
passages
through the amnions (Table 1).
Passage 1 and passage 6 Bl6-Fl0 cells were
95.7% and 94.7% viable,
respectively,
before
injection
into the murine tail
veins.
The number
of Bl6-Fl0 lung tumor nodules from amnion passages
one and six are listed
in Tables 2 and 3
respectively.
All mice that were completely
and
successfully
injected
with Bl6-Fl0 cells
developed
lung nodules.
The changes in nodule number and
color between passage one cells
and passage six
cells
were apparent
at the gross level.
Passage
one nodules were melanotic
(Fig. 2) while passage
six nodules were mostly amelanotic.
The size of
the lung nodules within individual
lobes varied
(Fig. 2).
Counting the amelanotic
nodules was
difficult
due to their
large number and amelanotic
appearance.
Therefore
only one set of lungs,
which was representative
of the passage six
tail-injection
regime, was meticulously
counted.
The set of lungs containing
amelanotic
nodules was

lung nodules
Bl6-Fl0 cells
2-11

>300
(707 actually

>300
counted)

Fig. 2. Lungs from a C57BL6 mouse injected
15
days earlier
with lx10 5 Bl6-Fl0 cells.
The
Bl6-Fl0 cells
had previously
been passed through
the amnion once.
Melanotic
nodules of variable
size are discernable
(arrows).
Bar= 1mm.
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served
to enrich
the fraction
of invasive
subpopulations
present
in the heterogeneous
parent
B16-FlO tumor stock.
Similar
enrichment
methodologies
have been used by Hart and Fidler
(1978)
and Poste
et al.
(1980)
to enhance
tissue
invasive
capabilities.
Recently,
Steeg and
coworkers
(1985)
demonstrated
the selective
capability
of the human amnion to the point
of
identifying
six specific
mRNAs from metastatic
cell
lines
whose translation
was quantitatively
increased
when compared
to the RNA from a benign
clone.
The murine
Bl6-Fl0
in vitro
invasion
rate
is
essentially
unchanged
infive
of the six
passages.
The one exception,
passage
number
four,
was significantly
higher
than the other
five
invasion
rates
(p>0.01).
The reason
for the
higher
invasion
rate
for passage
four is unknown.
It is difficult
to understand
why the rate
of
invasion
does not significantly
change with
passages
since
the amnion is reported
to select
a
population
of cells
with higher
metastatic
potential.
The lack of an increase
in invasion
rate
might suggest
that
invasion
is a random
event and that
it is by chance
that
after
six
passages
a population
with high metastatic
potential
is observed.
This suggestion
is
countered
by observations
that
metastasis
is a
selective
rather
than a random process
(Talmadge
and Fidler,
1982).
Additional
studies
will
be
needed
to clarify
the relationship
between
amniotic
invasion
and tumor colony
formation
in
vivo.
The injection
of first
passage
and sixth
passage
Bl6-Fl0
cells
into
the lateral
tail
veins
of C57Bl6 mice resulted
in a >10 fold
increase
in
lung tumors
(29+12 to >300).
In actuality,
the
increase
may be->24
fold
if all
of the passage
six mice had as many tumors as was meticulous
y
counted
for the one passage
six animal.
It is an
established
procedure
to stop counting
murine
lung nodules
at 300 since
further
counting
is
difficult
if not technically
impossible
(Fidler,
1978).
Together,
this
in vitro
- in vivo tandem
protocol
showed the Bl6~10
cells
to be both
invasive
and metastatic.
Increased
metastasis
with passage
indicates
that while
there
exists
no
correlation
of the number of cells
penetrating
the membrane with colonization
number,
the
increase
in specific
activity
for colonization
appears
correlated
with increased
number of
passages
through
the membrane.
In contrast,
other
studies
have noted
a positive
correlation
of increased
invasion
rates
with increased
metastasis
(Brunson
et al.,
1978; Poste
et al,,
1980; Tullberg
and Burger,
1985; Terranova
e:
al.,
1986).
It is tempting
to speculate
why some
studies
show a correlation
in invasive
rate
to
that of metastasis.
There are at least
two
important
aspects
that
must not be
overlooked,
however,
in trying
to interpret
the varying
results.
The first
point
is that most invasion
rates
are low.
Studies
have indicated
invasion
rates
of Bl6 cells
to be less
than 5% (Hendri;
et
al.,
1985; Persky
et al.,
1986).
Other studi,s
indicate
the survival
rate
of cells
to form
secondary
growths
to be approximately
1% or less
(Fisher
and Fisher,
1967; Fidler,
1970; Weiss
1980).
Methodologies
to determine
changes
in

arbitrarily
chosen
from the eleven
sets
of lungs
available
for evaluation
(Table
3).
Gross pathological
examination
of all animals
only identified
one potential
extrapulmonary
metastatic
nodule.
This nodule
was present
subcutaneously
on the dorsal
scapular
surface
of
the right
forelimb
of a passage-one
animal.
The
nodule
had the same coloration
as that
animal's
pulmonary
nodules.
Positive
diagnosis
of the
melanotic-like
nodule
at the electron
microscopic
level
was not done.
Transmission
electron
microscopy
of Bl6-Fl0
cells
before
the initial
plating
onto the amnion
revealed
stage
III premelanosomes.
Similarly,
electron
microscopic
evaluation
of passage
one
and passage
six Bl6-Fl0
cells
demonstrated
stage
III premelanosomes
(Figure
3).
Lung biopsies
of
melanotic
nodules
(passage
one and passage
six)
and amelanotic
nodules
(passage
six)
were also
positively
identified
as melanoma by the presence
of stage
III premelanosomes.
Scanning
electron
microscopy
of intact
amnions
revealed
a monolayer
of epithelial
cells
(Figure
4).
In contrast,
scanning
electron
microscopy
of ammonium hydroxide
treated
amnions
showed the absence
of epithelial
cells
(Figure
5).
Preformed
channels
through
which tumor cells
could
passively
migrate
were not observed.
Discussion
The purpose
of this
study
is to test
the
invasiveness
of Bl6-Fl0
cells
using
the human
amniotic
basement
membrane model.
This study
also
determines
if invasiveness
is increased
with
repetitive
cell
passages
through
the amnion and
if repetitive
cell
passages
through
the amnion
have subsequent
effects
on tumor nodule
formation
in the murine
lung.
It is paramount
to work with
cells
that are invasive
when studying
invasion.
Two murine
cell
lines
were originally
selected
for this
investigation
due to their
reported
invasive
capability
through
type IV collagen,
the
collagen
type found in basement
membranes
(Liotta
et al.,
1980b).
These two murine
cell
lines,
Bl6-Fl0
and Bl6-BL6,
were evaluated
in vitro
and
in vivo (unpublished
data).
AlthoughB16-BL6
cellshave
a greater
level
of type IV
collagen-degrading
activity
than Bl6-Fl0
cells
(Liotta
et al.
1980b),
and although
collagenase
may be the critical
enzyme in Bl6-Fl0
cell
invasion
through
the human amnion
(Persky
et al.,
1986) the Bl6-Fl0
cell
line
was chosen
for this
study
as the preferred
cell
line
because
of
better
invasion
rates
in the HABM model.
In this
study
the Bl6-Fl0
cells
were
determined
to be invasive
by their
invasion
through
the amnion and were determined
to be
tumorigenic
by the in vivo lung nodules.
Additionally,
extrapulmonary
metastases
were rare
as only one potential
extrapulmonary
nodule
was
noted
in all
17 autopsied
animals.
This
observation
of low extrapulmonary
metastasis
accompanying
high lung colonization
is in
agreement
with Fidler
(1973,
1975).
A function
of the amnion is to select
from
the functionally
heterogeneous,
phenotypically
homogeneous
B16-FlO population
a subpopulation
with differing
invasive
capabilites.
The amnion

856

In vitro

vs.

in vivo

Fig.
5,
Scanning
electron
denuded
amnion.
Treatment
hydroxide
has removed
the
Bar=
1 mm.

rates

these
small
invasive
cell
populations
may not
adequately
discriminate
the de facto
condition.
The second
point
is that all
in vitro
tumor
models developed
to date do not perfectly
reflect
the in vivo condition
and as tumor models may
represent
different
components
of the metastatic
process.
Although
it is necessary
to dissect
the
metastatic
process
into
its various
components
in
order
to better
understand
metastasis,
conceptualizationof
the entire
metastatic
process
must not be lost
in evaluating
individual
components,
such as invasion,
Although
the
amnion assay
of Liotta
and coworkers
(1980a),
the
canine
vein assay
of Poste
et al.
(1980),
the
nuclepore
filter
assay
of Tullberg
and Burger
(1985),
and the reconstituted
membrane assay
of
Terranova
et al.
(1986)
evaluate
invasiveness
through
a biological
or artificial
membrane
barrier,
there
may be little
correlation
between
the models.
For example,
tumor cell
substrate
for these
four assays
could
be epithelium/denuded
basement
membrane/connective
tissue
stroma,
endothelium/connective
tissue,
filter
paper,
and
laminin/type
IV collagen
respectively.
Since
cell
attachment
is a required
step
in the process
of invasion,
all
four invasive
assays
may largely
reflect
differences
in substrates
for cell
attachment.
For example,
it has been recently
demonstrated
that
monoclonal
antibodies
which
interfere
with cellular
adhesion
to laminin
and
which prevent
adherence
of Bl6 cells
to tissue
culture
dishes
reduce
Bl6 experimental
lung
metastases
(Vollmers
et al.,
1984).
It is worth
noting
that
passage
one lung
nodules
were essentially
melanotic
whereas
passage
six lung nodules
were mainly
amelanotic.
This change
in phenotypic
appearance
from
melanotic
to amelanotic
may be related
to
increased
metastatic
potential.
It should
be
noted,
however,
that
there
is no unequivocal
definitive
correlation
between
degree
of
pigmentation
and metastatic
potential
(Fidler
et
al.,
1981).
There
is a positive
correlation
between
successive
passages
through
the amnion
and metastatic
potential
as seen by log increases
in the number of lung colonies
with amniotic
passages
one and six cells.
Transmission
electron
microscopy
(TEM) was
used to verify
that
the original
stock
of Bl6-Fl0
cells
plus
the invasive
cells
of amnion passages
one and six were melanoma.
In addition,
TEM
positively
identified
lung nodules
as melanoma.
The definitive
diagnosis
of melanoma was made by
finding
stage
III premelanosomes,
which are the
best
ultrastructral
marker
for melanoma
(Mackay
and Osborne,
1978).
Ideally,
experiments
to determine
the
effects
of successive
cell
passages
through
the
amnion would eliminate
the tissue
culture
phase
of the protocol.
Tissue
culture
was needed
in
this
study
to increase
the number of cells
available
for seeding
onto the amnion,
The
selective
capability
of the amnion
to
discriminate
more invasive
cells
might be
compromised
by the ability
of these
cells
to
attach
to flasks
and grow in tissue
culture.
Perhaps
the subpopulation
of cells
that
pass
through
the amnion has a minor subpopulation
that
will
attach
and grow in culture.
Perhaps
the

Fig.
3.
Transmission
electron
micrograph
of
stage
III premelanosomes
(arrows).
The premelanosomes
are from a melanotic
lung nodule
taken from a passage
one mouse,
Bar=
0.2 µm.

Fig. 4.
Scanning
electron
micrograph
intact
amnion,
The epithelial
cell
complete.
Bar=
1 mm.

invasion

of an
layer
is

micrograph
of a
with ammonium
epithelial
cell
layer.
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selective
capability
of the amnion is thus being
diluted
by increasing
the number of cells
via
tissue
culture
techniques
(in vitro)
rather
than
in vivo techniques.
Work byFidler
(1973)
suggests
that
this
is not the case,
however,
as
in vitro
culture
did not reduce
the relative
metastatic
abilities
of his Bl6 tumor lines.
It
is theoretically
possible
to avoid
increasing
the
stock
of passage
one cells
without
injecting
cells
into syngenic
mice (in vivo method)
or by
growing
them in tissue
culture(in
vitro
method).
However,
such a protocol
would require
a gigantic
"industrial
size"
set up for passage
one cells
since
only approximately
2% of the plated
cells
would be expected
to pass through
the amnion.
In summary,
the HABM model in conjunction
with the MICS chamber
provided
a very
satisfactory
method for quantification
of
invasion
and retrieval
of invading
cells.
The in
vivo lung data were interpreted
as showing
thatthe HABM selected
a more tumorigenic
subpopulation
of cells.
However,
this
selection
of a more tumorigenic
cell
subpopulation
in vivo
was not correlated
to increased
invasion
rates
in
vitro.
Lung nodules
from passage
six cells
were
mainly
amelanotic
while
lung nodules
from passage
one cells
were melanotic,
thereby
demonstrating
heterogeneity
in the original
Bl6 stock.
We
concluded
that
the use of an in vivo host,
such
as C57BL6 mice,
is needed
to demonstrate
that
the
in vitro
HABMassay
has selected
a special
subpopulation
of cells.
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with
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rates

lung mets.
is puzzling.
A previous
in vivo study
by Ostrowski
et al.
(text
reference
#l7)With
the
same DCT cell
shipment
showed a range of 30 to 127
lung mets in six of seven similar
experiments.
There is,
therefore,
strong
evidence
that
the
shipped
cells
routinely
produce
lung mets.
below
the 150-250
range.
In order
to further
address
the criticism
of too low a number of lung mets.,
A.S. Bajkowski
(Loyola
University
of Chicago,
Department
of Biochemistry
and Biophysics)
recently
ordered
Bl6Fl0
cells
(#8547,
passage
unknown,
medium MEM with 107. FCS, date frozen
4/16/85)
and Bl6Fl cells
(#G00031,
passage
unknown,
medium MEM with 107. FCS, date frozen
8/1/85)
from NIH.
Although
there
was
approximately
a five
fold difference
in the number
of lung mets.
obtained
from tail
vein injections
of Bl6Fl and Bl6Fl0
cells
(unpublished
data),
the
overall
number of lung mets.
for both cell
lines
was drastically
reduced
from values
in the
literature.
It is highly
unlikely
that
three
independent
investigative
laboratories
(B. Persky,
L.E.
Ostrowski
and R.M Schultz,
and A.S. Bajkowski)
following
similar
protocols
injected
too few
cells.
It is also unlikely
that
the tail
vein
injections
were improper
since
the personnel
making the injections
each have a minimum of two
years
of tail
vein injections.
Although
the three
laboratories
and Loyola's
Animal Research
Facility
have had no problems
with
the health
of mice,
viral
contamination
cannot
be
ruled
out.
Mice held in conventional
animal
quarters,
such as Loyola's
animal
quarters,
routinely
contract
virus
but have subclinical
manifestations.
Clinical
manifestations
were not
seen in the animal
quarters
or in the
laboratories.
We have no way of determining
if we were
accidently
sent
the Bl6Fl cell
line
instead
of the
Bl6Fl0
cell
line,
It is unlikely,
but
theoretically
possible.

Reviewers

L.A. Repesh:
After
reviewing
several
published
pafers
using
the same assay with Bl6Fl0
cells
(5 x
5
10 - 1 x 10 cells
in 0.2 ml per animal
via the
tail
vein),
the mean number of pulmonary
nodules
that develop
is significantly
higher
(e.g.
Gehlsen
KR, Hendrix
MJC (1986).
Cancer Letters,
30:
207-212;
225 + 37.2 metastatic
colonies)than
what
the authors
report
here (29.0 + 12,3 metastatic
colonies
for first
passage
Bl6Fl0
cells).
Please
comment.
M.J.C.
Hendrix:
Regarding
the in vivo results,
the reported
number of lung mets":" from p - l
Bl6Fl0
cells
is unacceptably
low, according
to
several
published
results.
This number should
fall
within
a 150 - 250 met, range per animal,
However,
the reported
low number of mets.
would be
acceptable
for the metastatic
potential
of B16Fl
cells.
Please
comment.
Authors:
These reviewer
statements
are extremely
important
as they challenge
a fundamental
aspect
of the study.
Questions
that
could be derived
from the statements
would include
the following:
Why were there
so few metastatic
lung nodules?
Were too few tumor cells
injected?
Were the tail
vein injections
properly
administered?
Were the
C57/BL6 mice virally
infected?
Did the authors
receive
the correct
murine cell
line or perhaps
the murine
Bl6Fl cell
line by mistake?
Answers
to
these
questions
follow.
Upon receiving
the cells
from the DCT Tumor Repository,
the shipped
cells
were immediately
characterized
by transmission
electron
microscopy
as being melanoma due to the
presence
of stage
III premelanosomes.
Stage
III
premelanosomes
provide
definitive
diagnosis
for
melanoma
(text
reference
#15).
The cells
were
also
shown to be tumorigenic
via subcutaneous
injections
and metastatic
via tail
vein injections
(unpublished
data).
Only after
having
been shown
to be melanotic,
tumorigenic,
and metastatic
were
the shipped
cells
accepted
into
the authors'
laboratory
as Bl6Fl0
cells.
Why there
were so few

B. Forslind:
You do not express
overtly
that
the
passage
through
a basement
membrane selects
for
tumor cells
with high capacity
for metastasis.
Would you agree
with such a generalized
opinion?
Authors:
Yes.
We had hoped to see not only an
increase
in lung mets.,
but also
an increase
in
the invasion
rate
in the HABM assay.
The HABM
assay
is used to evaluate
the properties
of
invasion.
Invasion
is a subset
of the larger
process
of metastasis.
Therefore,
explaining
the
in vivo metastatic
process
solely
by the in vitro
HABMassay
data would be unjustified,
Thet'f't'Ie
of our paper was carefully
chosen
to reflect
a
comparison
of in vitro
and in vivo data.
It is of
interest
to note
that a rec-;iitly
published
paper
(Gehlsen
KR, Hendrix
MJC (1986).
Cancer Letters,
30: 207-212.)
demonstrated
no significant
difference
in the invasion
profiles
of Bl6Fl and
B16Fl0 cells
in the MICS in vitro.
In addition,
the metastatic
potentialsof
both the Bl6Fl and
Bl6Fl0
cell
lines
were confirmed
in vivo to be
unequivocally
different.
The results
of Gehlsen
and Hendrix
thus agree
with our results
in that
cells
with different
metastatic
potential
in vivo
do not have different
invasive
profiles
invitro
when using
the HABM assay
with the MICS apparatus.
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B. Persky

and G.W. Chmielewski
L.A. Repesh:
In what manner were the membranes
examined for leakiness
before the addition
of the
cells
to the upper wells?
Authors:
Membranes were initially
examined for
tears or rips while in the embroidery
ring and
again when being inserted
into the MICS chamber.
Finally,
leakiness
of individual
wells was
evaluated
by reviewing
the standard
error values
for each invasion
rate (see text Table I).
The
standard
error rates suggest
that individual
wells
did not leak.
As for determining
if an entire
amnion was leaky, the statistical
comparison
between individual
invasion
rates based on least
significant
difference
values suggests
that
amnions from passages
1,2,3,5,
and 6 are
significantly
different
(p<0.01)
than the amnion
of passage 4. Therefore
the entire
amnion #4
might have been leaky.
However, leaky here should
mean a "thinner"
amnion membrane rather
than a
damaged amnion membrane (hole,
rip, tear),
Bl6Fl0
cells have been known to invade more quickly
through thinner
amnion membranes.
Amnion
thickness
is discussed
in the following
reviewer
question.

Reviewer IV: Is it possible
to show micrographs
of tumor cells
trapped in the amnion, i.e.
in the
process of migrating
through the amnion by either
histological
section
or TEM.
Authors:
Please see Figure 6.
Reviewer IV: Perhaps the authors
could enlighten
us about the structures
seen in the denuded
amnion.
A histological
section
could verify
the
absence of epithelium
and will be more informative
to the reader than the existing
micrograph.
Authors:
Please see Fig. 7 for a higher
magnification
of the denuded amnion.
The absence
of amniotic
epithelium
is also seen in the
histological
section
illustrated
in Fig. 6.
Reviewer IV: A photographic
comparison of
melanotic
nodules from passage one and passage six
in terms of size and number of nodules would be
helpful.
Granted the passage six nodules are
mainly amelanotic
they are easily
visualized
by
fixation
of the tissues
in Bouin's
fixative
and
has been used extensively
by I.J.
Fidler.
L.A. Repesh:
A figure demonstrating
the gross
appearance
of passage six cells
should have been
included
for comparison
to passage one cells.
Authors:
Please see Figure 8.

L.A. Repesh:
Have you considered
variations
in
the thickness
of the amniotic
membrane as a factor
for the similar
invasive
profiles
of Bl6Fl0 tumor
cell variants?
Authors:
We are well aware of variations
in the
thickness
of the human amnion.
L.A. Liotta,
who
is credited
with developing
the amnion assay (text
reference
#13), continues
to stress
that one of
the problems with the amnion assay is variability
from amnion to amnion (Welch DR (1986). Discussion
of the suitability,
availability,
and requirements
for in vivo and in vitro models of metastasis.
In: Welch DR, Bhuyan BK, Liotta
LA (eds.)
Progress
in Clinical
and Biological
Research.
Volume 212, Cancer Metastasis
Experimental
and
Clinical
Strategies,
p. 134. New York: Alan R.
Liss, Inc.).
Two papers which demonstrate
and
discuss
both intra-amniotic
and inter-amniotic
variations
in thickness
are text reference
#10 and
Persky B, Grganto DM (1987). Diffusion
of dextrans
and microspheres
in the human amniotic
basement
membrane model.
Clin. Expl. Metast.,
in press.

Reviewer IV: Does TEM of amelanotic
nodule also
show premelanosomes?
If so, how much when
compared with the stock or with the melanotic
nodules.
Authors:
Premelanosomes
are observed by TEM in
amelanotic
nodules.
However, unlike both the
original
stock of B16Fl0 cells
and the various
melanotic
nodules,
there were fewer stage III and
stage IV (fully
melanized)
premelanosomes,
There
appeared
to be more abnormal stage I and stage II
premelanosome development
in the amelanotic
nodules.
Text reference
#15 provides
morphological
descriptions
of amelanotic
and
melanotic
tumors with regard to tumor diagnosis.
B. Forslind:
Are there any data to suggest
thst
the specific
cell line used in your work has a
collagenase
that is purely specific
for the type
IV collagen
of the basement membrane or does it
have a broader spectrum of capacities?
Further
is
there in your work any suggestion
that the amount
of collagenase
produced by the tumor cells
is
correlated
to the invasive
capacity
of the tumor
cells?
Authors:
Liotta
et al, (text reference
#14) have
shown the Bl6Fl0 cell line to have a collagenase
that is highly specific
for type IV collagen,
i.e.
basement membrane collagen,
and is different
from
collagenase
that cleaves
collagen
types I,II,
and

L.A. Repesh:
Have you considered
that the
similarity
in the invasive
profiles
of first
and
sixth passage Bl6Fl0 melanoma cells could be
attributed
to incompatability
interactions
between
human amnion and murine tumor cell antigens?
Authors:
Numerous immunological
studies
have
demonstrated
invasion
to be dependent,
in part, on
tumor cell antigenicity.
Since the amnion has
been treated with Na0H, the amniotic
epthelium has
been removed and fibroblasts
in the collagenous
stroma have been killed.
Thus the amnion is
essentially
an acellular
collagenous
stroma with
an overlying
basement membrane.
To the best of
our knowledge,
there has been no evidence of
incompa tabi li ty in t.erac tions in the HABMassay
literature
between human amnions and murine tumor
cells.

III.

We have not measured the amount of
collagenase
produced by tumor cells.
However,
Liotta
et al. (text reference
#14) have identified
type IV collagenase
activity
in Bl6Fl0 cells and
have determined
that the amount of collagenase
activity
is directly
correlated
to the invasive
capacity
of various
tumor cell lines.
Thus
Liotta's
study of enzymatic degradation
of
basement membrane collagen
showed the following
cell lines to have increasing
type IV collagenase
activity:
Bl6Fl, Bl6Fl0, B16BL6, and PMT.

L.A. Repesh:
How did you determine
that l x 10 5
cells was an appropriate
number of cells
to seed
in the upper wells of the MICS chamber?
Was
nutrient
depletion
and cell crowding considered?
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We have previously
plated 2 x 10 3 to 1 x
cells
per ml in the MICS chamber.
From
data collected
from cell viability,
which served
1
1
:: 0 :g~~~~et~:
:~:~i:~=t~:~
:~!~:ra:~
;e~ 104 to l
x 10 was determined
to be optimum.
This range of
cells
is supported
by the work of Hendrix et al.
(text reference
#10) where 2.5 - 5 x 104 cells/ml
was determined
to be optimum for plating.
Authors:

Tel6 Bl6Fl0

M.J.C. Hendrix:
It is difficult
for CO to
2
diffuse
adequately
from the incubator
to the lower
wells over a 3 day period.
Was this controlled
for in any way?
Authors:
The ability
of co to diffuse
into the
2
lower wells is important.
One way to "control"
the co level in the lower wells was to maintain
a
2
5% CO2 level in the VWR 1810 automataic
incubator.
The water pan was emptied and refilled
every 7-14
days to help stabalize
the CO2 concentration.
The
incubator
is checked yearly w!th a fyrite
tester
to determine
the accuracy
of the automatic
co
level.
It would be possible
to further
enhance2
CO2 diffusion
by (1) redesigning
the MICS chambers
or (2) using a pump to circulate
the media from
the bottom wells to the 5% CO atmosphere
of the
2
incubator.
Ron Misiorowski
(University
of
Arizona,
Department
of Anatomy) has discussed
such
modificataions
with us (personal
communication).

----·t

L.A. Repesh:
In what passage were the melanoma
cells
that were used?
Authors:
The passage of the B16F10 cells
as
received
from the DCT Tumor Repository
was
unknown.
The cells
used for passage 1 were from a
frozen stock in our laboratory
dated 11-30-84.
The same stock of cells
had been previously
shown
by our labortory
to be tumorigenic
(subcutaneous
injections),
metastatic
(tail
vein injections),
and melanotic
(TEM identification
of stage III
premelanosomes).

Fig. 6. This light micrograph
illustrates
B16Fl0
cells
on the basement membrane and a Bl6F10 cell
(arrow) in the process
of migrating
through the
collagenous
stroma of the amnion.
Note that the
amniotic
epithelium
is absent due to the NaOH
treatment.
Hematoxylin
and Eosin.
Bar= 10 mm.
Fig. 7. This SEM micrograph
reveals
an intact
continuous
basement membrane surface.
The
epithelium
has been completely
removed.
The thin
avascular
stroma of the amnion is not visible
as
it lies below the basement membrane.
Bar= 5 mm.
Fig. 8.
These lungs from a C57/BL6 ~ouse were
injected
15 days earlier
with 1 x 10 B16F10
cells.
The B16F10 cells had previously
been
passed through the amnion six times.
Amelanotic
(white arrow) and melanotic
(black arrow) nodules
of variable
size are discernable.
Unlike the
fresh lung tissue
illustrated
in Fig. 2, this lung
tissue
was immersed in Bouin's fixative
immediately
after
the lung nodules were counted.
Tumor nodules,
especially
amelanotic,
were more
easily
visualized
after
being preserved
in Bouin's
fixative.
Bar=
1 mm.
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B. Persky

and G.W. Chmielewski
L.A. Repesh:
Was it verified
that the serum
concentration
used in the amnion assay was optimal
for cell growth?
Authors:
We have cultured
murine melanoma cells
in the MICS chamber for 72 hours in 0%, 2%, 5%,
acid inactivated
5%, and 10% fetal
calf serum
(FCS).
Cells grew best in 10% FCS. We now
utilize
the MICS assay with 10% FCS unless serum
must be deleted,
as in proteolytic
enzyme
investigations
(text reference
#20).
Hendirx et
al. (text reference
#10) have published
growth
curves for different
concentrations
of serum (1%,
2.5%, 5%, and 10%) for use in the MICS chamber and
have shown 10% FCS as the optimum serum
concentration
for cell growth. However, Hendrix
often used 5% FCS in the MICS chamber as the
optimum serum concentration
permitting
both cell
growth and cell invasion
(personal
communication).

M.J.C. Hendrix:
Even though the authors
were
extremely
honest in the presentation
of data
regarding
the presence
of amelanotic
nodules
in p
- 6 injected
mice, counting
only one set of lungs
does not render statistically
relevant
data for
evaluation.
L.A. Repesh:
Only one pair of lungs from animals
injected
with sixth passage Bl6Fl0 were
"meticulously"
quantitated.
All the lungs should
have been counted for statistical
analysis
to be
more relevant.
Authors:
Fidler
(text
reference
#5), Ostrowski
(text reference
#17) and ourselves
have found it
difficult,
if not impossible,
to accurately
identify
individual
melanotic/amelanotic
tumors in
excess of 300 mets per lung.
After a point
counting
tumor mets. in the lung becomes
subjective
because of the vast merging together
of
various
mets.
The message of Tables II and III
(see text)
is that the mean and standard
deviation
of lung nodules
for passage
1 (29.0 + 12.3) and
for passage 6 (>300 in all animals)
Ts greater
than a log difference.
Therefore
there is a
significant
difference
in the number of mets.
between the two groups.

L.A. Repesh:
What is the total
volume of the
upper and lower wells of the MICS chamber?
Authors:
The upper and lower wells in our
particular
MICS chambers are routinely
filled
l.O and l.l-1.2
ml of fluid respectively.

with

L.A. Repesh:
Since the MICS chambers have side
ports for sampling,
why were the membranes
pierced?
Could this procedure
have allowed for
contamination
of the lower wells with cells
from
corresponding
upper wells?
Other studies
using
this technique
have shown great variability
in
cell counts from well to well.
Authors:
There are various models of the MICS
apparatus.
All MICS chambers used in this study
did not have side ports.
At no time were
membranes pierced
in order to sample the contents
of the lower wells.
Contamination
of the lower
well is known to occur with the "pipette-puncture
method" (unpublished
data and text reference
/flO).
We have modified
the MICS chambers since the
completion
of this experiment.
Access ports are
on the bottom of the chamber rather
than the side.

M.J.C. Hendrix:
Percent
invasion
cannot be
accurately
quantitated
the way it is outlined
in
this paper.
It does not take into consideration
the rate of cell division
in the upper wells and
in the lower wells of the MICS chambers.
After 3
days, some cell division
must have occurred.
Authors:
In this study the percent
invasion
rate
was defined
as the number of cells
per ml of fluid
in the bottom well of a MICS chamber divided
by 1
x 10 5 (number of cells
plated
per ml into the top
well).
Comparison of invasion
rates
could be made
since the definition
of precent
invasion
was
applied
equally
to all parameters
of the
experiments.
The important
message of our study
is that the invasion
profile
of passage
1 and
passage 6 cells
remained relatively
unchanged.
After the completion
of our study,
a study was
published
demonstrating
no significant
difference
in the invasion
profiles
of Bl6Fl and Bl6Fl0 cells
in the MICS appartus
in vitro
(Gehlsen KR, Hendrix
MJC (1986).
Cancer Letters;--50:
207-212.).
The
results
of these two papers compliment
each other
in that low and high metastatic
cells,
as
determined
in vivo, pass through
the amnion with
appearantlysimilar
invasive
profiles.
Cell division
is known to occur in the upper
and lower wells (text
reference
#10) and in the
amnion membrane itself
(Mignatti
P, Robbins E,
Rifkin DB (1986).
Tumor Invasion
through
the Human
Amniotic Membrane:
Requirment
for a Proteinase
Cascade.
Cell 47: 487-498.).
However, the rate of
cell division
is reduced in the amnion as compared
to the upper and lower wells.

M.J.C. Hendrix:
How long did it take for the
cells
that invaded the amnion to come to
confluency?
Authors:
Cells that invaded the amnion were not
grown to confluency.
Instead
cells
were grown to
near confluency
in order to optimize
conditions
for logrithmic
growth.
The mean number of days
for growing cells
to near confluency
from one
passage to the next was 19.6 days.
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